|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
29.440 -0.740 (-2.452%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 7,595,424 | 17.924% | 6,440,951 | 5,604,463 | 5,640,118 | 4,634,585 |
| Cost of Sales | (5,120,555) | 19.954% | (4,268,750) | (3,756,412) | (3,602,677) | (3,021,474) |
| Gross Profit | 2,474,869 | 13.934% | 2,172,201 | 1,848,051 | 2,037,441 | 1,613,111 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (16,970) | -54.312% | (37,143) | (22,940) | (10,713) | (6,339) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 20,324 | -- | (32,657) | (30,306) | 10,982 | (4,439) | |
| Profit / (Loss) before Taxation | 926,178 | 13.955% | 812,756 | 1,226,851 | 908,525 | 742,698 | |
| Taxation | (214,475) | 33.941% | (160,126) | (143,905) | (124,457) | (177,398) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 38,491 | -21.070% | 48,766 | 30,457 | 2,025 | 20,132 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 750,194 | 6.957% | 701,396 | 1,113,403 | 786,093 | 585,432 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 76,957 | 0.323% | 76,709 | 87,373 | 74,792 | 57,933 |
| Depreciation & Amortisation | 722,396 | 18.537% | 609,426 | 554,813 | 481,689 | 340,423 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 41.380 | 3.865% | 39.840 | 62.820 | 44.420 | 32.940 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 8.934 | -- | 8.056 | 7.280 | 6.345 | 5.573 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 750,194 |
| %Change | 6.957% |
| EPS / (LPS) | RMB 0.414 |
| NBV Per Share (¥) | RMB 8.934 |